Submit your business proposal
English
企業情報
チーム
ファンド
投資先企業
ニュース
お問い合わせ
ESG Policy
ビジネス提案書の提出はこちら
English
企業情報
チーム
ファンド
投資先企業
ニュース
お問い合わせ
ESG Policy
ニュース
News type
記事
イベント
プレスリリース
地域
日本
EU
最新ニュース
16th 4月 2024
Acticor Biotech will present the clinical results of its phase 2/3 ACTISAVE study in the treatment of stroke at ESOC 2024
Read more
22nd 3月 2024
SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 11.5 MILLION IN AN EQUITY PLACEMENT
Read more
15th 3月 2024
Acticor Biotech completes a capital increase for a total gross amount of 8 million euros
Read more
26th 1月 2024
Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure
Read more
26th 1月 2024
PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions
Read more
4th 1月 2024
Sequana Medical granted US CPT® III reimbursement codes for alfapump® system
Read more
30th 11月 2023
Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure
Read more
30th 11月 2023
Acticor Biotech completes a capital increase for a total gross amount of approximately 2.6 million euros, via the issuance of 850,360 shares
Read more
29th 11月 2023
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Read more
1
2
3
4
Sign up
You are added to the list, thank you!